Welcome to our dedicated page for Carvana SEC filings (Ticker: CVNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Carvana Co. SEC filings document the reporting framework for an online used-vehicle retailer with Class A and Class B common stock. Recent 8-K filings furnish shareholder letters, press releases, and conference-call materials covering quarterly and annual operating results, retail unit activity, revenue, profitability measures, expense trends, and the company's vertically integrated automotive e-commerce model.
Carvana's proxy and material-event filings also cover governance and capital-structure matters. These disclosures include annual meeting votes, executive compensation and pay-versus-performance information, the Carvana Co. 2026 Omnibus Incentive Plan, amendments to the company's certificate of incorporation, a five-for-one forward stock split, and related authorized share increases for its common stock classes.
Carvana Co. insider plans additional stock sale under Rule 144. A holder has filed to sell 20,000 shares of Carvana common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $9,454,600.00. The filing notes 141,423,193 common shares outstanding.
The 20,000 shares were acquired on 12/12/2025 by exercising stock options granted by the issuer, paid in cash on the same date. The planned sale is part of a broader selling pattern under a 10b5-1 sales plan for the BHJC Trust, which sold 40,000 shares on 12/08/2025, 10,000 shares on 12/01/2025, 10,000 shares on 11/03/2025, and 10,000 shares on 10/01/2025, for disclosed gross proceeds on each date.
Carvana Co. shareholder Paul Breaux filed a notice of proposed stock sales under Rule 144. The filing covers the planned sale of 8,473 shares of Carvana common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $3,962,567.91. These shares were acquired on 12/11/2025 via an exercise of stock options paid in cash on the same date.
The notice also reports prior Rule 10b5-1 plan sales over the past three months. Breaux sold 20,000 common shares on 12/08/2025 for gross proceeds of $8,770,000.00 and 15,000 common shares on 10/01/2025 for gross proceeds of $5,970,000.00. The representation in the filing states that the seller does not know of any undisclosed material adverse information about Carvana’s operations.
Carvana Co. reported insider activity by an officer serving as President, Special Projects. On 12/08/2025, the insider exercised 20,000 stock options for Class A common stock at an exercise price of $10.07 per share and acquired the same number of shares. That day, the insider reported multiple sales of Class A common stock, including 20,000 shares at $429 per share, 952 shares at $434.77 per share, and 10,000 shares at $450 per share. After these transactions, the insider directly held 79,880 shares of Class A common stock and 161,282 stock options. The filing states that the option exercise and sales were carried out under a Rule 10b5-1 trading plan adopted on August 8, 2025.
Carvana Co.’s Chief Product Officer, Daniel J. Gill, reported multiple option exercises and stock sales on December 8, 2025. He exercised several tranches of stock options to acquire Class A common stock at exercise prices ranging from $10.07 to $296.05 per share. On the same date, he sold a total of 80,000 Class A shares in two transactions at prices of $429 and $450 per share. After these transactions, he directly beneficially owned 191,106 shares of Carvana Class A common stock. The filing notes that the option exercises and sales were carried out under a Rule 10b5-1 trading plan adopted on December 13, 2024.
Carvana Co. executive Benjamin E. Huston, the Chief Operating Officer, reported insider transactions in the company’s Class A common stock. On 12/08/2025, he exercised 40,000 stock options at an exercise price of $10.07 per share, acquiring the same number of Class A shares. That same day, he reported two sales of 20,000 shares each, at prices of $429 and $450 per share. Following these transactions, Huston reported owning 100,758 Class A shares directly and 368,513 stock options.
The filing notes that the option exercises and sales were carried out under a Rule 10b5-1 trading plan adopted on December 13, 2024, which is a pre-arranged plan intended to allow insiders to trade shares over time according to set instructions. The non-qualified stock options exercised were part of a grant that vested 25% on April 1, 2024 and then monthly over the following three years, conditioned on Huston’s continued service with Carvana.
Carvana Co. executive Paul Breaux reported option exercises and share sales. On 12/08/2025, he exercised 9,121 stock options for Class A common stock at an exercise price of $10.07 per share and acquired the same number of shares. That day he sold a total of 20,000 Class A shares in two transactions at prices of $429 and $448 per share, leaving him with 69,289 shares beneficially owned directly.
The transactions were carried out under a Rule 10b5-1 trading plan adopted on June 10, 2025. Following the exercise, Breaux retained 145,741 stock options with a $10.07 exercise price, exercisable through 02/22/2033. These non-qualified stock options vested 25% on April 1, 2024 and continue to vest monthly over the following three years, conditioned on his continued service with Carvana as Vice President, General Counsel, Secretary, and Chief Compliance Officer.
Carvana’s Form 144 filing reports a planned insider sale of common stock. The notice covers 80,000 common shares to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $31,981,600. The filing notes 141,423,193 shares of the same class outstanding.
The seller acquired the 80,000 shares on 12/08/2025 by exercising stock options and paid the purchase price in cash on the same date. The form also includes a standard representation that the seller does not know of undisclosed material adverse information about the issuer’s current or prospective operations.
An existing holder of CVNA common stock has filed a notice of proposed sale of 40,000 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $15,990,800.00 and 141,423,193 shares of common stock outstanding. The shares to be sold were acquired on 12/08/2025 via an exercise of stock options paid in cash on the same date.
Over the past three months, a 10b5-1 sales plan for BHJC Trust reported additional sales of CVNA common stock: 10,000 shares on each of 10/01/2025, 11/03/2025, and 12/01/2025, with gross proceeds of $3,892,725.00, $3,245,730.00, and $3,771,101.00, respectively.
CVNA filed a Form 144 notice for a proposed sale of 20,000 shares of its common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,995,400. The filing notes that 141,423,193 shares of common stock were outstanding. The seller acquired 10,879 shares on 10/01/2024 via restricted and performance stock units from the issuer and 9,121 shares on 12/08/2025 through a cash exercise of stock options.
Over the past three months, the same person, identified in 10b5-1 sales as Paul Breaux, sold 15,000 common shares on 10/01/2025 for gross proceeds of $5,970,000 and another 15,000 common shares on 09/09/2025 for $5,625,000. By signing, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
CVNA insider Thomas Taira has filed a notice of proposed sales of up to 30,952 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 12,373,681.04. The filing reports that 141,423,193 common shares were outstanding.
The shares to be sold come from two sources: 20,000 shares acquired on 12/08/2025 through a cash exercise of stock options, and 10,952 shares from restricted and performance stock units granted on 07/19/2023. The notice also lists prior Rule 10b5-1 sales over the past three months, including 25,000 shares sold on 12/03/2025 for gross proceeds of 10,000,000.00, 10,000 shares on 11/28/2025 for 3,750,126.00, and 952 shares on 11/10/2025 for 309,400.00.